Home / Available CME / ICAAC 2011 eSymposium

ARV Therapies and Therapeutic Strategies Reporting From The 51st Interscience Conference on Antimicr

ICAAC_2011_eSymposium_Webpage_Banner.jpg

ICAAC11eSymp_OnDemand_Button.jpg

ICAAC11eSymp_OnDemand_Spanish_Button.jpg

ICAAC11eSymp_OnDemand_French_Button.jpg 

ICAAC11eSymp_Download_SlidePres_Button.jpg

About the Program

Program Overview

This 1.5 hour Internet symposium will review and discuss the key studies on antiretroviral therapy presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy. 

Back to Top   

Target Audience

This activity is intended for physicians, physicians' assistants, advanced practice nurses and other health care professionals involved in the treatment and management of patients with HIV infection.

Back to Top

Learning Objectives

After completing this activity, participants should be able to:

  • Explain the key new studies on ARV therapy presented at the 51st ICAAC; 

  • Outline how to use the advances in clinical management of HIV-positive patients presented and discussed at the 51st ICAAC to improve patient care;

  • Describe how to apply data presented at the 51st ICAAC regarding the treatment of ARV-naïve and experienced patients;

  • Formulate appropriate ARV regimens for HIV-positive patients.

Release Date: September 27, 2011
Expiration Date: September 27, 2012

Estimated time to complete this on-demand Web symposium: 1 hours, 45 minutes

Media: Internet

Back to Top

Faculty

José Arribas, MD
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain

John Bartlett, MD
Professor, Johns Hopkins University
School of Medicine
Baltimore, Maryland

Calvin J. Cohen, MD, MS
Research Director,
CRI New England
Clinical Instructor,
Harvard Medical School
Boston, Massachusetts

Jürgen Rockstroh, MD
Professor, University of Bonn
Bonn, Germany

Andrew Zolopa, MD
Associate Professor of Medicine,
Division of Infectious Diseases
Stanford University School of Medicine
Palo Alto, California

Back to Top  

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Postgraduate Institute for Medicine and ViralEd, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.   

Back to Top

Credit Designation

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine assesses conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Postgraduate Institute for Medicine for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Postgraduate Institute for Medicine is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jose Arribas, MD

  • Consulting Fees: Merck; Abbott; Tibotec; Janssen; Gilead; GlaxoSmithKline; Pfizer; Biogen; Avexa; Bristol-Myers Squibb; ViiV

John Bartlett, MD

  • Nothing to Disclose

Calvin Cohen, MD

  • Consulting Fees: Gilead; Bristol-Myers Squibb; Merck; Tibotec; Abbott 
  • Fees for Non-CME/CE Services: Gilead; Bristol-Myers Squibb; Merck; Tibotec
  • Grants/Research Steering Committee: Gilead; Bristol-Myers Squibb; Merck; Tibotec; ViiV
 Juergen Rockstroh, MD
  • Contracted Research: Abbott; Merck; Roche
  • Consulting Fees: Abbott; Bristol-Myers Squibb; BI; Merck; Roche; GlaxoSmithKline; Pfizer; Gilead; Tibotec; ViiV
 Andrew Zolopa, MD
  • Consulting Fees: Gilead; Tibotec; Bristol-Myers Squibb 
  • Contracted Research: Bristol-Myers Squibb; Pfizer; Gilead; VIRxSyS

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchinson, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; Patricia Staples, MSN, NP-C, CCRN, Brian Boyle, MD hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine, ViralEd, LLC and Merck & Co. do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Postgraduate Institute for Medicine, ViralEd, LLC and Merck & Co. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Instructions for Participation and Credit 

There are no fees for participating and receiving credit for this activity. During the period, September 27, 2011 through September 27, 2012 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.

To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

You may complete the post-test online at: www.cmeuniversity.com

  • Click on "Find Post-Test/Evaluation by Course" on the navigation menu
  • Search by project ID: 8341
  • Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately
  • Back to Top

    Disclaimer 

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Back to Top

    Hardware and Software Requirements 

    This program requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

    PIM_small

     Supported by an educational grant from Merck & Co., Inc.

    This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings

    Click Logo above to contact PIM


    Recommend this page to a friend! Prepare to print

    Share this page:

    Get link code to this page                     


    Back to Top